Our data showed that LASS2 overexpression promotes iron uptake by upregulating TFRC expression in thyroid and breast cancer cell lines while simultaneously reducing iron storage by downregulating FTL and FTH expression, thereby elevating labile iron, which further confers ferroptosis sensitivity. The gene discussed is CERS2; the disease is breast carcinoma.